Our findings demonstrated that the miR-103a-3p-LATS2/SAV1-YAP1-HIF1A regulatory axis contributes to a better understanding of the molecular mechanisms of glycolysis in CRC, which would lay a theoretical foundation for molecular targeted therapy of CRC. Here, HIF1A is linked to colorectal carcinoma.